within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H05A_ParathyroidHormonesAndAnalogues.H05AA03_ParathyroidHormone;

model ParathyroidHormone
  extends Pharmacolibrary.Drugs.ATC.H.H05AA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H05AA03</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Parathyroid hormone (PTH) is an endogenous peptide hormone used as a diagnostic agent and as recombinant formulations (e.g., teriparatide) for osteoporosis treatment. Full-length recombinant PTH (rhPTH 1-84, ATC code H05AA03) is approved for hypoparathyroidism. Its actions include increasing blood calcium levels by stimulating osteoclasts, renal calcium reabsorption, and activating vitamin D.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following a single subcutaneous administration of recombinant human parathyroid hormone (rhPTH 1-84) 100 μg in healthy adult subjects, mixed sex.</p><h4>References</h4><ol><li><p>Whyte, MP, et al., &amp; Landy, H (2012). Enzyme-replacement therapy in life-threatening hypophosphatasia. <i>The New England journal of medicine</i> 366(10) 904–913. DOI:<a href=&quot;https://doi.org/10.1056/NEJMoa1106173&quot;>10.1056/NEJMoa1106173</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22397652/&quot;>https://pubmed.ncbi.nlm.nih.gov/22397652</a></p></li><li><p>Clarke, BL, et al., &amp; Lagast, H (2014). Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. <i>Clinical therapeutics</i> 36(5) 722–736. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2014.04.001&quot;>10.1016/j.clinthera.2014.04.001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24802860/&quot;>https://pubmed.ncbi.nlm.nih.gov/24802860</a></p></li><li><p>Moen, MD, &amp; Scott, LJ (2006). Recombinant full-length parathyroid hormone (1-84). <i>Drugs</i> 66(18) 2371–2385. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200666180-00008&quot;>10.2165/00003495-200666180-00008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17181378/&quot;>https://pubmed.ncbi.nlm.nih.gov/17181378</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ParathyroidHormone;
